Review article · 2023 · Open access
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Frontiers in Oncology, 13, 1143798 · Published 7 March 2023 · DOI 10.3389/fonc.2023.1143798
In brief
“Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer” is a 2023 review article by Rui Ni and 6 co-authors, published in Frontiers in Oncology. OpenAlex counts 66 citations as of 22 November 2026, which puts it in the top 3% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Oncology.
- Citations
- 66
- Most cited in
- 2025 (26)
- Field-weighted impact
- 1.60
- References
- 254
- Authors
- 7
Abstract
Glutamine, the most abundant non-essential amino acid in human blood, is crucial for cancer cell growth and cancer progression. Glutamine mainly functions as a carbon and nitrogen source for biosynthesis, energy metabolism, and redox homeostasis maintenance in cancer cells. Dysregulated glutamine metabolism is a notable metabolic characteristic of cancer cells. Some carcinogen-driven cancers exhibit a marked dependence on glutamine, also known as glutamine addiction, which has rendered the glutamine metabolic pathway a breakpoint in cancer therapeutics. However, some cancer cells can adapt to the glutamine unavailability by reprogramming metabolism, thus limiting the success of this therapeutic approach. Given the complexity of metabolic networks and the limited impact of inhibiting glutamine metabolism alone, the combination of glutamine metabolism inhibition and other therapeutic methods may outperform corresponding monotherapies in the treatment of cancers. This review summarizes the uptake, transport, and metabolic characteristics of glutamine, as well as the regulation of glutamine dependence by some important oncogenes in various cancers to emphasize the therapeutic potential of targeting glutamine metabolism. Furthermore, we discuss a glutamine metabolic pathway, the glutaminase II pathway, that has been substantially overlooked. Finally, we discuss the applicability of polytherapeutic strategies targeting glutamine metabolism to provide a new perspective on cancer therapeutics.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023). Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer. Frontiers in Oncology, 13, 1143798. https://doi.org/10.3389/fonc.2023.1143798
MLA 9
Ni, Rui, et al. “Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.” Frontiers in Oncology, vol. 13, 2023, p. 1143798. https://doi.org/10.3389/fonc.2023.1143798.
Chicago
Ni, Rui, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, and Yao Liu. 2023. “Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.” Frontiers in Oncology 13: 1143798. https://doi.org/10.3389/fonc.2023.1143798.
Harvard
Ni, R. et al. (2023) ‘Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer’, Frontiers in Oncology, 13, p. 1143798. doi:10.3389/fonc.2023.1143798.
IEEE
R. Ni et al., “Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer,” Frontiers in Oncology, vol. 13, p. 1143798, 2023, doi: 10.3389/fonc.2023.1143798.
BibTeX
@article{ni2023rethinking,
title = {{Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer}},
author = {Ni, Rui and Li, Ziwei and Li, Li and Peng, Dan and Ming, Yue and Li, Lin and Liu, Yao},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
pages = {1143798},
doi = {10.3389/fonc.2023.1143798},
url = {https://doi.org/10.3389/fonc.2023.1143798}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 6 | |
| 2024 | 13 | |
| 2025 | 26 | |
| 2026 | 21 |
Its field-weighted citation impact is 1.60: it has been cited 1.60 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- glutamine metabolism
- glutamine addiction
- oncogenes
- cancer metabolism
- metabolic reprogramming
- combination therapy
- cancer therapeutics
- redox homeostasis
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023). Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer. Frontiers in Oncology, 13, 1143798. https://doi.org/10.3389/fonc.2023.1143798
How many times has this paper been cited?
66 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Oncology: sign in and open the PDF from this page.
Who wrote this paper?
Rui Ni, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, Yao Liu.
What is the DOI of this paper?
10.3389/fonc.2023.1143798, permanently at https://doi.org/10.3389/fonc.2023.1143798. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.